v3.25.0.1
Consolidated statements of cash flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income (loss) $ 18,246 $ 3,681 $ (71,487)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 10,476 5,987 10,185
Amortization of premium and accretion of discount on marketable securities, net (4,753) (730) 6,385
Amortization of discount and issuance costs of convertible notes 2,555 2,541 2,527
Share -based compensation 73,942 68,698 71,755
Exchange rate fluctuations and other items, net 226 71 5
Impairment of intangible assets 0 0 27,629
Impairment of lease ROU asset 0 211 0
Revaluation of earn-out 3,202 (570) (12,249)
Changes in assets and liabilities:      
User funds (1,707) (8,582) (15,307)
Operating lease ROU assets and liabilities (104) (205) (1,485)
Other receivables (18,316) (2,877) (4,847)
Trade payables (409) (3,195) (113)
Deferred revenue 2,275 (306) (792)
User accounts (512) 9,171 14,416
Payment of earn-out (843) 0 (504)
Escrow Payment for contingent consideration (12,168) 0 0
Account payables, accrued expenses and other 7,967 8,232 3,994
Non-current liabilities 2,991 1,059 0
Net cash provided by operating activities 83,068 83,186 30,112
Investing activities:      
Investment in marketable securities (87,340) (309,155) (141,701)
Proceeds from maturities of marketable securities 159,216 273,186 130,701
Investment in short-term bank deposits (66,357) 0 0
Proceeds from short-term bank deposits 8,213 46,858 0
Acquisition of business, net of cash acquired (39,738) 0 0
Acquisition of intangible asset (1,106) 0 (175)
Purchase of property and equipment (1,303) (1,053) (1,198)
Capitalization of internal-use software (103) (60) (1,000)
Other receivables and non-current assets (300) 0 (1,251)
Net cash provided by (used in) investing activities (28,818) 9,776 (14,624)
Financing activities:      
Repurchases of ordinary shares (100,081) 0 0
Proceeds from exercise of share options 3,349 2,765 3,765
Payment of earn-out (4,357) 0 (1,105)
Proceeds from (payments of) withholding tax related to employees’ exercises of share options and RSUs 859 87 (2,028)
Repayment of debt to previous shareholder of the acquired business (3,992) 0 0
Repayment of long-term loan 0 0 (2,269)
Net cash provided by (used in) financing activities (104,222) 2,852 (1,637)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash (230) (29) (32)
Increase (decrease) in cash, cash equivalents and restricted cash (50,202) 95,785 13,819
Cash, cash equivalents and restricted cash at the beginning of the year 183,674 87,889 74,070
Cash, cash equivalents and restricted cash at the end of the year 133,472 183,674 87,889
Supplemental non-cash disclosure:      
Purchase of property and equipment 129 153 208
Share-based compensation capitalized in internal-use software 32 0 274
Other expenses capitalized in internal-use software 335 0 50
Lease liabilities arising from obtaining right-of-use assets 1,236 465 359
Supplemental cash flow disclosure:      
Cash paid for income taxes 5,726 589 235
Cash paid for interest 118 145 246
Reconciliation of cash, cash equivalents and restricted cash:      
Cash and cash equivalents 133,472 183,674 86,752
Restricted cash 0 0 1,137
Total cash, cash equivalents and restricted cash $ 133,472 $ 183,674 $ 87,889